Evaluation and Management of Thyroid Nodules and Thyroid Cancer

Date:
Apr 28, 2022 from 7 a.m. - 8 a.m. (ET)

Overview

Please join us for “Evaluation and Management of Thyroid Nodules and Thyroid Cancer,” a virtual lecture from the Pediatric Thyroid Center at Children’s Hospital of Philadelphia.

The incidence of thyroid nodules and thyroid cancer is increasing in both pediatric and adult patients. Thyroid ultrasound and fine needle aspiration are the foundation of evaluation, however, there is increasing data on how to incorporate molecular testing to increase the accuracy of diagnosis, stratify surgery and even individualize therapy using tumor-specific systemic therapy for patients with advanced disease. We will review these topics with the goal of providing attendees with an introduction to the state-of-art approach to evaluation and care of thyroid nodules and thyroid cancer in 2022.

Objectives

  1. Define risk factors for developing thyroid nodules and thyroid cancer in children and adolescents.
  2. Describe the evaluation of thyroid nodules and how to incorporate the results into clinical practice.
  3. Discuss management of thyroid cancer and how genetic data is being incorporated to stratify care.

Speaker

  • Andrew Bauer, MD, Medical Director of the Pediatric Thyroid Center; attending endocrinologist; Associate Professor of Pediatrics, Perlman School of Medicine at the University of Pennsylvania  

Register now

ACCME Accreditation Statement: Children’s Hospital of Philadelphia is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement: Children's Hospital of Philadelphia designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Statement: Katie Lockwood, MD (Course Director) and Monica S. Williams (CME Planner) and others as appropriate have no relevant financial relationship with an ineligible company to disclose. 

Andrew Bauer, MD (Speaker) has a financial relationship that has been mitigated though the CHOP CE Peer-Review Mitigation Process.

Contact

For more information, contact Shelly Norbury at norburyS@chop.edu or 856-397-5588.

Related Specialties: Endocrinology; Hematology/Oncology